KMKai Ma

Kai Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kai Ma has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Ahuan Mm Xie

    Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

    1 shared publication
  • Baihua Zhang

    Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China

    1 shared publication
  • Baohui Zhang

    Department of Physiology, School of Life Science, China Medical University, Shenyang, China

    1 shared publication
  • Baoping Cao

    Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing, 100853 China

    1 shared publication
  • Bin Han

    Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China

    1 shared publication
  • Chenglin Yang

    National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen China

    1 shared publication

Latest Publications

  • Open Access

    E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma

    by Shengcheng Mm Lin, Xiangyang Yu, Haojie Yan, Yafei Mm Xu, Kai Ma, Xiaoliang Mm Wang, Yeqing Mm Liu, Ahuan Mm Xie, Zhentao Yu

    E2F transcription factors (E2Fs) are a family of transcription factors critical regulators of the cell cycle, apoptosis, and differentiation, thus influencing tumorigenesis. However, the specific roles of E2Fs in lung adenocarcinoma (LUAD) remain unclear. Data from The Cancer Genome Atlas (TCGA) were used. R version. 4.0.3 and multiple databases (TIMER, cBioportal, gene expression profile interaction analysis [GEPIA], LinkedOmics, and CancerSEA) were utilized to investigate mRNA expression, mutational analysis, prognosis, clinical correlations, co-expressed gene, pathway and network, and single-cell analyses. Immunohistochemistry (IHC) confirmed that E2F transcription factor 7 (E2F7) correlated with LUAD. Among the E2Fs, E2F7 was identified by constructing a prognostic model most significantly associated with overall survival (OS) in LUAD patients. The univariate and multivariate Cox regression analyses showed that E2F7, p-T stage, and p-TNM stage were closely related to OS and progression-free survival (PFS) (P < .05) in LUAD. E2F 7/8 were also identified as significantly associated with tumor stage in the GEPIA database. Compared with paracancerous tissues, E2F7 was up-regulated in LUAD by IHC, and E2F7 might be positively correlated with larger tumors and higher TNM stages. E2F7 may primarily regulate DNA repair, damage, and cell cycle processes and thus affect LUAD tumorigenesis, invasion, and metastasis by LinkedOmics and CancerSEA. E2F7 serves as a potential prognostic biomarker for LUAD.


  • Open Access

    CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT/GPX4 pathway

    by Songhua Cai, Baohui Zhang, Chujian Huang, Youjun Deng, Chunguang Wang, Yikun Yang, Zichang Xiang, Yao Ni, Zhe Wang, Lixu Wang, et al.


  • Open Access

    Distal‐type bronchiolar adenoma of the lung harboring an EGFR exon 21 p.L858R mutation: A case report

    by Chenglin Yang, Xiaoliang Wang, Jiping Da, Kai Ma

    Here, we present a case of a distal‐type bronchiolar adenoma (BA) of the lung. BAs are benign lung tumors characterized by nodular proliferation of bilayered bronchiolar‐type epithelium with a continuous layer of basal cells. This patient underwent S3 segmentectomy following detection by computed tomography (CT) scan of a gradually enlarging ground‐glass nodule (GGO) over a five month period. Nodule morphology and immunophenotype were consistent with those of distal‐type BA of the lung. An epidermal growth factor receptor (EGFR) exon 21 p.L858R missense mutation was identified which, to the best of our knowledge, is the first case to be reported of a common gene mutation associated with non‐small cell lung cancer (NSCLC) being found in a BA lesion. Following surgery, the patient remains relapse‐free.Key points: Significant findings of the study: Pathological assessment of a lung nodule confirmed a papillary tumor with a double‐layered cell structure, less than typical cytoplasm, and a mixture of ciliated columnar and globular cells, consistent with a distal‐type bronchiolar adenoma. What this study adds: This is the first report of an EGFR exon 21 p.L858R mutation in a bronchiolar adenoma.


  • Open Access

    Totally mechanical linear stapled anastomosis for minimally invasive Ivor Lewis esophagectomy: Operative technique and short‐term outcomes

    by Hui‐Jiang Gao, Ju‐Wei Mu, Wei‐Min Pan, Malcolm Brock, Mao‐Long Wang, Bin Han, Kai Ma

    Background: Anastomosis is one of the important factors affecting anastomotic complications after esophagectomy, and multiple reports have compared anastomotic complications among various techniques. However, there is insufficient evidence in the literature to definitively recommend one anastomotic technique over another.Method: We retrospectively evaluated 34 consecutive patients who underwent an improved totally mechanical side‐to‐side: posterior‐to‐posterior linear stapled (TM‐STS) technique for minimally invasive Ivor Lewis esophagogastric anastomosis, performed by a single surgeon between February 2015 to November 2017. The operative techniques and short‐term outcomes are analyzed in this study.Results: There were no conversions to an open approach and a complete resection was achieved in all patients undergoing this improved procedure. During the first half of the series, the median operation time was 355 minutes, ranging from 257 to 480 minutes. Over the second half of this series, the median operation time was reduced to 256 minutes. There were no mortalities or serious postoperative complications. Only one patient (2.9%) had an anastomotic leak, which resolved without intervention. Another patient (2.9%) experienced transient, delayed conduit emptying which upper gastrointestinal radiography determined was due to a mechanical obstruction caused by an abnormally long gastric tube in the chest cavity.Conclusions: The results of our study suggest that this improved TM‐STS technique is safe and effective for minimally invasive Ivor Lewis esophagectomy, and can be considered as one of the alternative procedure for patients with lower esophageal as well as Siewert types I/II gastroesophageal junction carcinoma.


  • A tension tracheal diverticulum: recurrence after interventional sclerotherapy followed by transcervical resection

    by Hui-Jiang Gao, Lei Gong, Zhi-Hui Jiang, Yu-Cheng Wei, Kai Ma

    Tracheal diverticulum is a rarely congenital or acquired tracheal benign entity, characterized by round or spherical out-pouching of the tracheal wall. Most of the tracheal diverticula are asymptomatic disease, and therefore surgical treatment has not been widely reported. Symptomatic diverticula can accept conservative treatment such as anti-inflammatory, postural drainage, etc. Transcervical resection or endoscopic laser surgery or electrosurgery should be considered for patients with severe symptoms or combined with repeated tracheobronchial inflammation. However, there is still insufficient evidence to recommend the optimal therapeutic schedule at present. We describe a special tension tracheal diverticulum with rare symptoms of dysphagia and dizziness for the first time which has a recurrence after interventional sclerotherapy followed by transcervical resection.


  • Open Access

    The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma

    by Kai Ma, Baoping Cao, Mingzhou Guo

    Esophageal cancer is one of the most common malignancies in the world. Squamous cell carcinoma accounts for approximately 90 % of esophageal cancer cases. Genetic and epigenetic changes have been found to accumulate during the development of various cancers, including esophageal squamous carcinoma (ESCC). Tobacco smoking and alcohol consumption are two major risk factors for ESCC, and both tobacco and alcohol were found to induce methylation changes in ESCC. Growing evidence demonstrates that aberrant epigenetic changes play important roles in the multiple-step processes of carcinogenesis and tumor progression. DNA methylation may occur in the key components of cancer-related signaling pathways. Aberrant DNA methylation affects genes involved in cell cycle, DNA damage repair, Wnt, TGF-β, and NF-κB signaling pathways, including P16, MGMT, SFRP2, DACH1, and ZNF382. Certain genes methylated in precursor lesions of the esophagus demonstrate that DNA methylation may serve as esophageal cancer early detection marker, such as methylation of HIN1, TFPI-2, DACH1, and SOX17. CHFR methylation is a late stage event in ESCC and is a sensitive marker for taxanes in human ESCC. FHIT methylation is associated with poor prognosis in ESCC. Aberrant DNA methylation changes may serve as diagnostic, prognostic, and chemo-sensitive markers. Characterization of the DNA methylome in ESCC will help to better understand its mechanisms and develop improved therapies.